Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on bipolarity and currently lists participation information in France.
In Paris
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In NashvilleThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In HoustonThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Turkey.
In Kütahya
This study is recruiting. It focuses on anxiety and currently lists participation information in Germany, the Netherlands, Romania, Serbia, Spain, the United Kingdom, and the United States.
Multiple locations, including SyracuseThis study is recruiting in the United States. It is testing AGB101 for Schizophrenia.
In BaltimoreThis study is recruiting in the United States. It is testing clozapine for the Prevention of Violence for schizophrenia.
Multiple locations, including Los Angeles
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
Multiple locations, including HartfordThis study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In SalouëlThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.